Pay in 4 interest-free payments of $6.81 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Explore the case study and see how polymer science is shaping the future of drug development: USP Case Study Lupron Depot #USP #PolymerScience #DrugDevelopment #PharmaceuticalInnovation #LupronDepot #PLGA #Biopharma #QualityStandards #RegulatoryCompliance #LongActingInjectables To view or add a comment, sign in Poly(N-isopropylacrylamide) (PNIPAM) Consider how PNIPAM transforms a raw active ingredient into a stable, injectable formulation that releases drug precisely when needed
They say the peptide, which has already been tested in Europe in patients with acute lung injury, like pneumonia or trauma, and is being pursued in lung transplant patients as well, holds promise for a targeted therapy for acute nephritis
We run clinical trials for natural and biotics ingredients at the same rigorous standard as pharmaceutical research but with trial designs that actually fit what these interventions do
Persistent or severe reactions may indicate sensitivity to benzyl alcohol in bacteriostatic water
